Photonicare, Inc.

photonicare was founded out of a shared passion to develop a superior solution for middle ear issues, primarily in children. with $10 billion spent annually to manage ear infections, and a documented 50% misdiagnosis rate for primary care physicians, current tools used to diagnose fluid in the middle ear fail to reliably interpret the patient’s condition. the fda-cleared otosight™ middle ear scope by photonicare is a clinical diagnostic tool designed to eliminate subjectivity and speculation with a non-invasive and comprehensive assessment of middle ear fluid. otosight™ is indicated to not only visualize the presence of fluid, but also the fluid’s density, even in the presence of earwax. as a result, the simple-to-use otosight™ middle ear scope has a 90+% reader accuracy in determining the presence or absence of fluid in the middle ear. clinicians that have had an opportunity to use otosight™ consider it a game-changer. this is further demonstrated by multiple best-in-show product awar